Phase 3 multicenter randomized trial of PSMA PET/CT prior to definitive radiation therapy for unfavorable intermediate-risk or high-risk prostate cancer [PSMA dRT]: study protocol

BACKGROUND: Definitive radiation therapy (dRT) is an effective initial treatment of intermediate-risk (IR) and high-risk (HR) prostate cancer (PCa). PSMA PET/CT is superior to standard of care imaging (CT, MRI, bone scan) for detecting regional and distant metastatic PCa. PSMA PET/CT thus has the po...

Descripción completa

Detalles Bibliográficos
Autores principales: Calais, Jeremie, Zhu, Shaojun, Hirmas, Nader, Eiber, Matthias, Hadaschik, Boris, Stuschke, Martin, Herrmann, Ken, Czernin, Johannes, Kishan, Amar U., Nickols, Nicholas G., Elashoff, David, Fendler, Wolfgang P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8103642/
https://www.ncbi.nlm.nih.gov/pubmed/33962579
http://dx.doi.org/10.1186/s12885-021-08026-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8103642/
https://www.ncbi.nlm.nih.gov/pubmed/33962579
http://dx.doi.org/10.1186/s12885-021-08026-w

Ejemplares similares